Clinical Use of Dopamine Modulators as Third-Generation Antipsychotic Agents.
Limandri, Barbara J.
J Psychosoc Nurs Ment Health Serv
; 57(2): 7-11, 2019 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-30703220
Synthesis and biological evaluation of a series of novel pyridinecarboxamides as potential multi-receptor antipsychotic drugs.
Fast Versus Slow Strategy of Switching Patients With Schizophrenia to Aripiprazole From Other Antipsychotics.
Prediction of an Optimal Dose of Aripiprazole in the Treatment of Schizophrenia From Plasma Concentrations of Aripiprazole Plus Its Active Metabolite Dehydroaripiprazole at Week 1.
[Pharmacokinetics and safety of aripiprazole long-acting injection, following multiple deltoid administrations in schizophrenia patients in Japan].
Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approach.
Association between aripiprazole pharmacokinetics and CYP2D6 phenotypes: A systematic review and meta-analysis.
Molecular properties affecting fast dissociation from the D2 receptor.
[Pharmacology of antipsychotics at human dopamine D2 and D3 receptors].
Effect of valproate on the plasma concentrations of aripiprazole in bipolar patients.
Evaluation of Potential Pharmacokinetic Drug-Drug Interaction between Armodafinil and Aripiprazole in Healthy Adults.